James L Freddo Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James L Freddo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James L Freddo. James L Freddo is Chief Medical Officer in ANADYS PHARMACEUTICALS INC ($ANDS) and SVP, Drug Development and CMO in ANADYS PHARMACEUTICALS INC ($ANDS) and Director in Ignyta, Inc. ($RXDX).
Latest Insider Trading Transactions of James L Freddo
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 12 2018 | RXDX | Ignyta, Inc. | Freddo James L | Director | Option Exercise | D | 8.35 | 20,000 | 167,000 | 0 | |
Feb 12 2018 | RXDX | Ignyta, Inc. | Freddo James L | Director | Option Exercise | D | 5.75 | 15,000 | 86,250 | 0 | |
Feb 12 2018 | RXDX | Ignyta, Inc. | Freddo James L | Director | Option Exercise | D | 7.59 | 5,000 | 37,950 | 0 | |
Feb 12 2018 | RXDX | Ignyta, Inc. | Freddo James L | Director | Option Exercise | D | 8.95 | 24,000 | 214,800 | 0 | |
Feb 12 2018 | RXDX | Ignyta, Inc. | Freddo James L | Director | Option Exercise | D | 1.02 | 6,666 | 6,799 | 0 | |
Feb 12 2018 | RXDX | Ignyta, Inc. | Freddo James L | Director | Sell | D | 27.00 | 3,000 | 81,000 | 0 | 3 K to 0 (-100.00 %) |
Jun 19 2017 | RXDX | Ignyta, Inc. | Freddo James L | Director | Option Exercise | A | 8.35 | 20,000 | 167,000 | 20,000 | |
Jun 15 2016 | RXDX | Ignyta, Inc. | Freddo James L | Director | Option Exercise | A | 5.75 | 15,000 | 86,250 | 15,000 | |
Mar 21 2016 | RXDX | Ignyta, Inc. | Freddo James L | Director | Buy | P | 5.39 | 3,000 | 16,182 | 3,000 | 0 to 3 K |
Dec 12 2008 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 1.99 | 100,000 | 199,000 | 100,000 | |
Aug 06 2008 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 2.74 | 50,000 | 137,000 | 50,000 | |
Dec 11 2007 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | Chief Medical Offic ... | Option Exercise | A | 2.00 | 50,000 | 100,000 | 50,000 | |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | Chief Medical Offic ... | Option Exercise | A | 2.32 | 100,000 | 232,000 | 100,000 | |
Aug 15 2007 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | Chief Medical Offic ... | Buy | P | 2.25 | 5,000 | 11,250 | 13,000 | 8 K to 13 K (+62.50 %) |
Aug 15 2007 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | Chief Medical Offic ... | Buy | P | 2.20 | 5,000 | 11,000 | 8,000 | 3 K to 8 K (+166.67 %) |
Page: 1